A Critical Evaluation of Adenosine A2A Receptors as Potentially “Druggable” Targets in Huntington's Disease

E-ISSN： 1873-4286|14|15|1500-1511

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.14, Iss.15, 2008-05, pp. : 1500-1511

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Phosphodiesterases as Therapeutic Targets for Huntington’s Disease

Current Pharmaceutical Design, Vol. 21, Iss. 3, 2015-01 ,pp. : 365-377

Bentham Science Publishers

Access to resources Recommend Favorite

An Update on Adenosine A2A Receptors as Drug Target in Parkinson's Disease

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 10, Iss. 6, 2011-09 ,pp. : 659-669

Bentham Science Publishers

Access to resources Recommend Favorite

Pharmacology of adenosine A 2A receptors

By Ongini E. Fredholm B.B.

Trends in Pharmacological Sciences, Vol. 17, Iss. 10, 1996-10 ,pp. : 364-372

Elsevier

Access to resources Recommend Favorite

Novel therapeutic targets for Huntington’s disease

By Hannan Anthony J

Expert Opinion on Therapeutic Targets, Vol. 9, Iss. 4, 2005-08 ,pp. : 639-650

Informa Healthcare

Access to resources Recommend Favorite

Molecular Targets and Therapeutic Strategies in Huntington's Disease

Current Drug Targets-CNS & Neurological Disorders, Vol. 4, Iss. 4, 2005-08 ,pp. : 361-381

Bentham Science Publishers

Access to resources Recommend Favorite